Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs

NCT03984318 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT03984318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 12, 2018
Completion date
December 11, 2028
Enrollment
1,240 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer